Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
02/15/2011 | US7888366 2,4-diaminoquinazolines for spinal muscular atrophy |
02/15/2011 | US7888360 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
02/15/2011 | US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
02/15/2011 | US7888356 Antibiotics containing borinic acid complexes and methods of use |
02/15/2011 | US7888287 6-Amino-5-chloro-2-(4-chloro-2,6-difluoro-3-methoxy-phenyl)pyrimidine-4-carboxylic Acid Methyl Ester; preemergence herbicides; applying to the soil in rice fields; broad spectrum of weed control against woody plants, grasses and sedges as well as broadleafs |
02/15/2011 | US7887845 Antiviral compositions |
02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
02/15/2011 | CA2558272C Pyridone derivative |
02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
02/10/2011 | WO2011017296A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors |
02/10/2011 | WO2011017079A1 Process for the preparation and purification of etravirine and intermediates thereof |
02/10/2011 | WO2011016228A1 Method for producing 4,6-dialkoxy-2-cyanomethylpyrimidine and synthetic intermediate thereof |
02/10/2011 | WO2011015641A1 Novel viral replication inhibitors |
02/10/2011 | WO2011015526A1 Method for stereoselective synthesis of bicyclic heterocyclic compounds |
02/10/2011 | US20110034493 N1-sulfonyl-5-fluoropyrimidinone derivatives |
02/10/2011 | US20110034492 N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives |
02/10/2011 | US20110034491 5-fluoro-2-oxopyrimidine- 1(2h)-carboxylate derivatives |
02/10/2011 | US20110034490 N1-acyl-5-fluoropyrimidinone derivatives |
02/10/2011 | US20110034485 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
02/10/2011 | US20110034482 Amine salts of a crth2 antagonist |
02/10/2011 | US20110034477 Crystalline Polymorph of Doxazosin Mesylate (Form IV) and Process for Preparation Thereof |
02/10/2011 | US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
02/10/2011 | US20110034435 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers |
02/10/2011 | US20110034433 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
02/10/2011 | CA2769656A1 N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives |
02/10/2011 | CA2769421A1 Viral replication inhibitors |
02/10/2011 | CA2768510A1 N1-acyl-5-fluoropyrimidinone derivatives |
02/10/2011 | CA2767963A1 Stereoselective synthesis of bicyclic heterocycles |
02/09/2011 | EP2281812A1 Nitrogenous heterocyclic compound with insecticidal activity and its preparation and use |
02/09/2011 | EP2281810A1 Amide compounds, preparation methods and uses thereof |
02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
02/09/2011 | EP2280948A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers. |
02/09/2011 | EP2033637B1 Therapeutic or prophylactic agent for leukemia |
02/09/2011 | EP1689715B1 Tubulin inhibitors |
02/09/2011 | CN101970416A Methods of preparing quinazolinone derivatives |
02/09/2011 | CN101970415A 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
02/09/2011 | CN101970406A Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
02/09/2011 | CN101967128A Benzo uracil PNA (Peptide Nucleic Acid) monomer and intermediate thereof as well as preparation methods and applications of benzo uracil PNA and intermediate thereof |
02/09/2011 | CN101967127A Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs |
02/08/2011 | US7884204 Phenylalanine derivatives |
02/08/2011 | US7884202 Nucleobases are perfluoroalkylated in a one step process with a perfluoroalkyl halide in the presence of a sulfoxide, a peroxide and an iron compound; useful as medicinal drugs, intermediates for medicinal drugs and agricultural chemicals |
02/08/2011 | US7884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents |
02/08/2011 | US7884105 Squaric acid derivatives as inhibitors of histone deacetylase |
02/08/2011 | US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi |
02/08/2011 | US7884098 Anthranilamide inhibitors of aurora kinase |
02/08/2011 | CA2479906C Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
02/08/2011 | CA2459374C Photoactivable nitrogen bases |
02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
02/03/2011 | WO2011014535A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION |
02/03/2011 | WO2011012592A1 Dihydropyrimidone amides as p2x7 modulators |
02/03/2011 | US20110028503 Compositions and methods for inhibition of the jak pathway |
02/03/2011 | US20110028502 Dihydropyrimidone amides as p2x7 modulators |
02/03/2011 | US20110028433 Quinazolinone derivatives as tubulin polymerization inhibitors |
02/03/2011 | US20110028405 Sulfamides as zap-70 inhibitors |
02/03/2011 | US20110028337 Nucleobase characterisation |
02/03/2011 | CA2768396A1 Dihydropyrimidone amides as p2x7 modulators |
02/03/2011 | CA2766515A1 Compounds for the reduction of .beta.-amyloid production |
02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
02/02/2011 | EP2279178A1 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides |
02/02/2011 | EP2279173A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
02/02/2011 | EP2278973A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
02/02/2011 | EP2278881A1 Herbicidal compounds based on n-azinyl-n'-phenylsulfonylureas |
02/02/2011 | EP2089369B1 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
02/02/2011 | EP1606265B1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
02/02/2011 | CN101965338A Novel heterocycles |
02/01/2011 | US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound |
02/01/2011 | US7879863 Aniline derivatives |
02/01/2011 | US7879861 4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine, capable of both inhibiting epidermal growth factor receptors and damaging DNA; antitumor and antiproliferative agents |
02/01/2011 | US7879860 Variations in melting points, hygroscopicities, solubilities, flow properties and/or thermodynamic stabilities |
02/01/2011 | CA2551529C Amide derivative and medicine |
02/01/2011 | CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
01/27/2011 | WO2011011522A2 Potent small molecule inhibitors of autophagy, and methods of use thereof |
01/27/2011 | WO2011010967A1 Process for producing flurocytidine derivatives |
01/27/2011 | WO2011010174A1 Crystalline form i rosuvastatin zinc salt |
01/27/2011 | WO2010084050A3 Quinazolinone derivatives useful as vanilloid antagonists |
01/27/2011 | US20110021774 Method for producing pyrimidine compound |
01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
01/27/2011 | US20110021523 Aryl sulfonamides |
01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
01/27/2011 | US20110021459 Dutpase inhibitors |
01/27/2011 | CA2767772A1 Potent small molecule inhibitors of autophagy, and methods of use thereof |
01/26/2011 | EP2277877A1 Quinazoline derivatives as kinase inhibitors |
01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
01/26/2011 | EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors |
01/26/2011 | EP2276774A2 Therapeutic substances that modulate genome methylation |
01/26/2011 | EP2276747A1 Sulfonamides as zap-70 inhibitors |
01/26/2011 | EP2276346A2 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
01/26/2011 | EP2114903B1 Bicyclic pyrimidinones and uses thereof |
01/26/2011 | EP1856061B1 Tetrahydro- and dihydroquinazolinones |
01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
01/26/2011 | CN101955470A Potentiators of glutamate receptors |
01/26/2011 | CN101955466A Synthesis method of 5-trifluoromethyluracil |
01/26/2011 | CN101955465A 5-fluoropyrimidine-4(3H)-ketone compound and preparation method and application thereof |
01/26/2011 | CN101955464A 4-(4-methoxybenzylamino)-3-(5-nitro-4-thiocyanic acid pyrimidine-2-amino) benzonitrile, preparation method and application thereof |
01/26/2011 | CN101955463A Method for preparing rosuvastatin calcium intermediate |
01/26/2011 | CN101597265B Method for synthesizing bromacil technical |